Comprehensive Psychiatry
Volume 46, Issue 6 , Pages 447-452 , November 2005

Substance abuse and related diagnoses in early psychosis

  • Jyrki A. Korkeila

      Affiliations

    • Department of Psychiatry, Turku City Hospital and Turku University Central Hospital, University of Turku, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 40 5514249; fax: +358 269 2528.
    • ,
  • Tanja Svirskis

      Affiliations

    • Department of Psychiatry, University of Turku, 20700 Turku, Finland
    • ,
  • Markus Heinimaa

      Affiliations

    • Department of Psychiatry, University of Turku, 20700 Turku, Finland
    • ,
  • Terja Ristkari

      Affiliations

    • Department of Psychiatry, University of Turku, 20700 Turku, Finland
    • ,
  • Jukka Huttunen

      Affiliations

    • Department of Psychiatry, University of Turku, 20700 Turku, Finland
    • ,
  • Tuula Ilonen

      Affiliations

    • Department of Psychiatry, University of Turku, 20700 Turku, Finland
    • ,
  • Tom McGlashan

      Affiliations

    • Department of Psychiatry, University of Yale, New Haven, CT, USA
    • ,
  • Raimo K.R. Salokangas

      Affiliations

    • Department of Psychiatry, Turku City Hospital and Turku University Central Hospital, University of Turku, Finland
    • Department of Psychiatry, Psychiatric Clinic, Turku University Central Hospital, 20540 Turku, Finland

References 

  1. Häfner H, Riecher-Rössler A, Hambrecht M, et al. IRAOS: an instrument for the assessment of onset of early course of schizophrenia. Schizophr Res. 1992;6:209–223
  2. Zubin J, Spring B. Vulnerability—a new view of schizophrenia. J Abnorm Psychol. 1977;82:103–126
  3. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. J Am Med Assoc. 1990;264:2511–2518
  4. Kandel DB, Johnson JG, Bird HR, et al. Psychiatric comorbidity among adolescents with substance abuse disorders: findings from the MECA Study. J Am Acad Child Adolesc Psychiatry. 1999;38:693–699
  5. Cantor-Graae E, Nordström LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res. 2001;48:69–82
  6. Phillips P, Johnson S. How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol. 2001;36:269–276
  7. Gerra G, Zaimovic A. Exploring the biological relationship between substance use and psychiatric disorders. Curr Opin Psychiatry. 2002;15:269–275
  8. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med. 2003;33:23–32
  9. Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand. 1989;79:505–510
  10. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212–1213
  11. Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry. 1996;40:1155–1163
  12. Buhler B, Hambrecht M, Loffler W, an der heiden W, Häfner H, et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse—retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res. 2002;54:243–251
  13. Salokangas RKR, Heinimaa M, Ilonen T, Suomela T, Korkeila J, Plathin M, et al. Vulnerability to and risk of psychosis. Description, experiences and preliminary results of the Detection of Early Psychosis or DEEP project. Neurol Psychiat Brain Res. 2004;11:37–44
  14. Heinimaa M, Salokangas RKR, Ristkari T, Plathin M, Huttunen J, Ilonen T, et al. PROD-screen—a screen for prodromal symptoms of psychosis. Int J Methods Psychiatr Res. 2003;12:92–104
  15. Miller T, McGlashan T, Woods S, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Quat. 1999;70:273–289
  16. Miller T, McGlashan T, Rosen J, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structures interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863–865
  17. Cannon-Spooner HE, Plotkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bull. 1982;8:470–484
  18. Heinrichs D, Hanlon T, Carpenter W. The Quality of Life Scale: an instrument for rating schizophrenia deficit syndrome. Schizophr Bull. 1984;10:388–398
  19. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Soc Behav Sci Doc. 1987;[San Rafael, CA]
  20. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacology. 1973;9:13–28
  21. Hyler SE, Skodol AE, Kellman HD, Oldham JM, Rosnick L. Validity of the Personality Diagnostic Questionnaire—revised: comparison with two structured interviews. Am J Psychiatry. 1990;147:1043–1048
  22. Suomela T, Korkeila J, Heinimaa M, et al. Validity of the Personality Diagnostic Questionnaire—revised: comparison with two structured interviews. Schizophr Res. 2005;75:439–446
  23. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry. 1998;155:127–128
  24. Virtanen, A. Huumausainetilanne Suomessa 2001, Stakesin tilastoraportti 8/2001, Helsinki. (Available only in Finnish: Drug abuse situation in Finland, 2001. Statistical reports of the National Centre for Reserach and Development in Welfare and Health, Finland).
  25. Poikolainen K. Alcohol and mortality: a review. J Clin Epidemiol. 1995;48:455–465

PII: S0010-440X(05)00051-9

doi: 10.1016/j.comppsych.2005.03.008

Comprehensive Psychiatry
Volume 46, Issue 6 , Pages 447-452 , November 2005

Article Tools